久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • ViiV Healthcare receives MA in Europe for Dovato pharmaceutical-technology
    July 04, 2019
    The European Commission (EC) has approved ViiV Healthcare’s marketing authorisation application (MAA) for Dovato (dolutegravir/lamivudine), which is indicated to treat HIV-1 infection.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service